Micafungin: a new echinocandin antifungal.


The echinocandins represent the newest class of antifungals to combat infections caused by Candida sp. Micafungin is an echinocandin recently approved by the United States Food and Drug Administration. It is indicated in adults for esophageal candidiasis and prophylaxis against candidal infections in hematopoietic stem cell transplant recipients. Micafungin… (More)


Cite this paper

@article{Joseph2007MicafunginAN, title={Micafungin: a new echinocandin antifungal.}, author={Jomy Joseph and Rupali Jain and Larry H. Danziger}, journal={Pharmacotherapy}, year={2007}, volume={27 1}, pages={53-67} }